Legal & General Group
FMTX

Legal & General Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Legal & General Group’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,012
Closed -$240K – 3470
2022
Q3 		$240K Buy
12,012
+1,825
+18% +$24.1K ﹤0.01% 2558
2022
Q2 		$70K Buy
10,187
+3,670
+56% +$25.8K ﹤0.01% 2937
2022
Q1 		$61K Hold
6,517
– – ﹤0.01% 2970
2021
Q4 		$93K Hold
6,517
– – ﹤0.01% 2927
2021
Q3 		$150K Buy
6,517
+3,226
+98% +$76.3K ﹤0.01% 2759
2021
Q2 		$82K Sell
3,291
-537
-14% -$14.4K ﹤0.01% 2800
2021
Q1 		$107K Buy
3,828
+1,238
+48% +$44.7K ﹤0.01% 2603
2020
Q4 		$91K Buy
2,590
+781
+43% +$34K ﹤0.01% 2613
2020
Q3 		$90K Buy
+1,809
New +$73.1K ﹤0.01% 2520

Legal & General Group's FMTX Position: Q4 2022 in Review

Legal & General Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 12,012 shares — an estimated $240K sold.

Legal & General Group first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $240K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Legal & General Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 12,012 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $240K.
  • Legal & General Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Legal & General Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $240K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.